Blockbuster Dupixent wins FDA approval for COPD - STAT
WEB5 hours ago · Sept. 27, 2024. West Coast Biotech & Life Sciences Reporter. Dupixent is already a blockbuster therapy for a range of immune-mediated diseases, but the Food and Drug Administration’s approval of ...
FDA signs off on Regeneron and Sanofi's Dupixent for COPD
WEB5 hours ago · They based their figure on 30% uptake of the treatment for those who are eligible. The addition would put Dupixent’s sales potential at $20 billion by the end of this decade, making it one of ...
US FDA approves Sanofi-Regeneron's Dupixent for 'smoker's lung'
WEB5 hours ago · Sept 27 (Reuters) - The U.S. Food and Drug Administration has approved Sanofi , opens new tab and Regeneron's , opens new tab blockbuster drug Dupixent for patients with a chronic lung disease ...
Dupixent® (dupilumab) Approved in the U.S. as the First-ever …
WEB5 hours ago · “This latest FDA approval for Dupixent represents new hope for the hundreds of thousands of COPD patients in the U.S. who can sometimes struggle just to breathe during their everyday lives,” said George D. Yancopoulos, M.D., Ph.D., Board co-Chair, President and Chief Scientific Officer at Regeneron, and a principal inventor of Dupixent ...
FDA, after delay, clears Regeneron and Sanofi drug for COPD
WEB19 hours ago · European regulators approved Dupixent for COPD in July, but Regeneron and Sanofi have had to wait longer in the U.S., where the FDA requested additional efficacy data from the two trials. Over that time, a potential new competitor has emerged in GSK’s Nucala, which the FDA rejected in 2018 but earlier this month succeeded in a Phase 3 trial.
Dupixent® (dupilumab) Approved in the U.S. as the First-ever …
WEB19 hours ago · Dupixent is the leading biologic medicine for all of its FDA-approved indications in new-to-brand prescriptions, and the most prescribed biologic by pulmonologists in the U.S.
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
WEB19 hours ago · Green light covers Dupixent as an add-on maintenance treatment in certain adults with uncontrolled chronic obstructive pulmonary disease, or COPD. Regeneron REGN 1.83%increase; green up pointing ...
Press Release: Dupixent approved in the US as the first-ever
WEBSep 27, 2013 · George D. Yancopoulos, M.D., Ph.D. Board Co-Chair, President and Chief Scientific Officer at Regeneron “This latest FDA approval for Dupixent represents new hope for the hundreds of thousands of COPD patients in the US who can sometimes struggle just to breathe during their everyday lives. …
FDA approves new eczema drug Dupixent | FDA - U.S. Food and …
WEBThe U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose...
FDA greenlights Regeneron’s Dupixent for the treatment of COPD
WEB28 minutes ago · REGN. With the latest nod from the US Food and Drug Administration (FDA), Regeneron Pharmaceuticals and Sanofi have expanded the US label of Dupixent (dupilumab) to treat chronic obstructive ...